The coronavirus pandemic has caused havoc worldwide, with over 3,1 million confirmed COVID-19 cases and almost 218000 COVID-19 related deaths over time. Until an effective vaccine will have been created and will become widely available to the world population, the coronavirus remains a serious threat to global health. Several class action lawsuits, at least six, have been filed against the Chinese government and government departments in federal U.S. courts. The lawsuits are concerned with COVID-19 related losses, death and injuries. Also, several jurists worldwide are discussing whether China can be taken to the ICJ over the coronavirus pandemic.
The efforts to prevent further spread of the virus and to control further effects of the COVID-19 have resulted in a radically changed world, far-reaching consequences and a slowing down of physical globalization. The near standstill of global economic activity as a result of COVID-19 has led to a worldwide financial crisis with yet unforeseen consequences.
The first COVID-19 case is said to have occurred in China. It can be traced back to November 17, 2019 in China's Huibei province. Much later, on December 31, 2019, China informed the WHO of a pneumonia of an unknown source. It shared genetic information about the virus on January 12, 2020. There have been voices blaming China for failing to timely and adequately reporting to the WHO about the coronavirus outbreak and for not properly containing the spread of COVID-19. China has been accused of negligence in this regard, and of not being transparent about the true facts and figures regarding the COVID-19 outbreak. China was criticised for deliberately concealing facts with regard to the coronavirus.
Some describe COVID-19 as the 'Chinese virus'. Fear for COVID-19 has fueled xenophobia and racisim against people of Asian descent worldwide. A recent Chinese lawsuit pursues compensation for "reputational damage done by President Donald Trump's use of the phrase 'the Chinese virus' to describe the coronavirus".
Several class action lawsuits, at least six, have been filed against the Chinese government and government departments in federal U.S. courts. The lawsuits are concerned with COVID-19 related losses, death and injuries. However, law professor Stephen L. Carter from Yale University and several other jurists question the legal liability of these class action suits since it is hard to prove; there is no basis for jurisdiction in a U.S. court. Professor Carter explains that Nation-states are immune from such lawsuits.
The legal community also discusses whether China can be taken to the International Court of Justice over COVID-19. There are jurists who believe that China has committed an international wrongful act by failing to report to the WHO timely about the COVID-19 outbreak.
Several jurists agree that suing China before the ICJ would not be an easy task, but rather a "herculean" venture. Establishing the question of the dispute would be difficult and this makes the "probability of success very slim", says Atul Alexander, assistant professor of law at West Bengal National University of Juridical Sciences. Some jurists think that it is not worth considering to sue China before the ICJ. The ICJ can only exercise its jurisdiction when a State has given its consent, which is not the case. China has not given its approval. Alexander and others are of the opinion that rendering an advisory opinion of the ICJ could offer a safer and more advantageous option. Consent from the disputant parties is not necessary for invoking the advisory jurisdiction of the ICJ. Even though an advisory opinion from the ICJ is not legally binding, it could nevertheless help to set a precedent for the international community which would help to regulate the conduct of states. This would aid states to participate proactively in the fruitful functioning of the United Nations system, says Alexander.
It is clear that in spite of the legal consequences of the COVID-19 outbreak, international law and international cooperation are needed most to defeat the coronavirus pandemic. It is necessary to show solidarity in fighting COVID-19, especially to countries which have been affected the most. A good example of solidarity is the Coronavirus Global Response. This pledging event was convened on May 4, 2020. The event was started with the aim of raising funding for the development and universal deployment of diagnostics, vaccines and treatments against COVID-19. The initiative has been co-convened by several countries, including the EU, Germany, Norway, France, the United Kingdom, Spain, Italy, Japan, the Kingdom of Saudi Arabia and Canada.The donors have raised €7,4 billion in pledges.
- Bækkeskov, E., "Transboundary Crises : Organization and Coordination in Pandemic Influenza Response", in: Dahlberg, R. (et al.) (eds.), Disaster Research : Multidisciplinary and International Perspectives, London, Routledge, 2016, pp. 189-206.
- Beigbeder, Y., The World Health Organization: Achievements and Failures, Abingdon, Routledge, 2017.
- Bollinger, A.E., "E-Mers-Gency: an Application and Evaluation of the Pandemic Influenza Preparedness Framework to the Outbreak of MERS-CoV.", in:Temple International and Comparative Law Journal, Vol. 29 (2015), No. 1, pp. 1-24.
- Burci, G.L., and J. Quirin, Implementation of the International Health Regulations (2005): Recent Developments at the World Health Organization, Washington, DC, American Society of International Law, 2018.
- Burci, G.L. (ed.),Global Health Law (Vol 1), Cheltenham, Edward Elgar, 2016.
- Burci, G.L. (ed.),Global Health Law (Vol 2), Cheltenham, Edward Elgar, 2016.
- Burci, G.L. and B.C.A. Toebes (eds.), Global Health Law, Cheltenham, Edward Elgar, 2018.
- Carter, J., "WHO's Virus is it Anyway? : How the World Health Organization can Protect against Claims of "Viral Sovereignty"", in Burci, G.L. (ed.), Global Health Law (Vol. 2), Cheltenham, Edward Elgar, 2016, pp. 589-612.
- Campos, T. C. de, The Global Health Crisis : Ethical Responsibilities, Cambridge, Cambridge University Press, 2017.
- COVID Dossier (Articles in Dutch About COVID-19 and Law), Nederlands Juristen Blad. (Free online access).
- Enemark, C., Biosecurity Dilemmas : Dreaded Diseases, Ethical Responses, and the Health of Nations, Washington, DC, Georgetown University Press, 2017.
- Fidler, D.P., "The Future of the World Health Organization: What Role for International Law?", in : Burci, G.L. (ed.), Global Health Law (Vol. 1), Cheltenham, Edward Elgar, 2016, pp. 203-250.
- Fidler, D.P., "From International Sanitary Conventions to Global Health Security: The New International Health Regulations", in Burci, G.L. (ed.), Global Health Law (Vol 1), Cheltenham, Edward Elgar, 2016, pp.385-452.
- Fidler, D.P., "Negotiating Equitable Access to Influenza Vaccines : Global Health Diplomacy and the Controversies Surrounding Avian Influenza H5N1 and Pandemic Influenza H1N1", in: Rosskam, E. and I. Kickbusch (eds.), Negotiating and Navigating Global Health : Case Studies in Global Health Diplomacy, Singapore, World Scientific, 2011, pp. 161-172.
- Gatter, R., "The New Global Framework for Pandemic Influenza Virus- and Vaccine-Sharing", in: Cohen, I.G. (ed.), The Globalization of Health Care : Legal and Ethical Issues, New York, NY, Oxford University Press, 2013,pp. 272-285.
- Gostin, L.O., Global Health Law, Cambridge, Massachusetts, Harvard University Press, 2014.
- Freeman, M.D.A. (et al.) (eds), Law and Global Health, Oxford, Oxford University Press, 2014.
- Granziera, E., and S.A. Solomon, "The World Health Organization", in: Bowman, M. and D. Kritsiotis (eds.), Conceptual and Contextual Perspectives on the Modern Law of Treaties, Cambridge, Cambridge University Press, 2018, pp. 881-906.
- Kamradt-Scott, A., "The World Health Organization, Global Health Security and International Law", in: Nasu, H., and K. Rubenstein (eds.), Legal Perspectives on Security Institutions, Cambridge, Cambridge University Press, 2015, pp. 225-247.
- Lee, K. and D.P. Fidler, "Avian and Pandemic Influenza: Progress and Problems with Global Health Governance", in Burci, G.L. (ed.),Global Health Law (Vol 1), Cheltenham, Edward Elgar, 2016, pp 453-472.
- Meisterhaus, N., "The World Health Organization in Crisis-Lessons to be Learned Beyond the Ebola Outbreak", in The Chinese Journal of Global Governance Vol. 2 (2016), No. 1, pp. 1-29.
- Nasu, H. and K. Rubenstein (eds.), Legal Perspectives on Security Institutions,Cambridge, Cambridge University Press, 2015.
- Regis, C. and F. Kastler, "Improving the World Health Organization’s Normative Strategy with Respect to Global Health Goals: What Should We Aim For?", in Revue Belge de Droit International : Publication Semestrielle du Centre de Droit International de l'Institut de Sociologie de l'Université Libre de Bruxelles et du Centre de Droit International de l'Université Catholique de Louvain,Vol. 51 (2018), No. 1, pp. 138-151.
- Samuel, K. (et al.) (eds.), The Cambridge Handbook of Disaster Risk Reduction and International Law, Cambridge, Cambridge University Press, 2019.
- Stanton, C., and H. Quirk (eds.), Criminalising Contagion : Legal and Ethical Challenges of Disease Transmission and the Criminal Law, Cambridge, Cambridge University Press, 2016.
- Vierck, L. (et al.) (eds.), The Governance of Disease Outbreaks : International Health Law: Lessons from the Ebola Crisis and Beyond, Baden-Baden, Nomos, 2017.
- Villareal, P.A., "The World Health Organization's Governance Framework in Disease Outbreaks: A Legal Perspective" , in Vierck, L. (et al.) (eds.), The Governance of Disease Outbreaks : International Health Law: Lessons from the Ebola Crisis and Beyond, Baden-Baden, Nomos, 2017, pp. 243-272.
- Villareal, P.A., "Pandemic Declarations of the World Health Organization as an Exercise of International Public Authority : The Possible Legal Answers to Frictions Between Legitimacies", in Goettingen Journal of International Law, Vol. 7 (2016), No. 1, pp. 95-129.
- WHO, International health regulations (2005), Geneva : World Health Organization, 2008.
- Youde, J.R., Global Health Governance in International Society, Oxford, Oxford University Press, 2018.